What David Einhorn’s Apple Inc. (AAPL) Idea Means for Investors

Page 1 of 2

David Einhorn GREENLIGHT CAPITALAs far as Apple Inc. (NASDAQ:AAPL) bulls go, hedge fund superstar David Einhorn is about as vocal as they come. The fund manager has long been extremely bullish on the Mac maker’s fundamental business and is a notable investor in the company with over 1.3 million shares. He’s also making headlines today because his company, Greenlight Capital, is suing Apple Inc. (NASDAQ:AAPL).

What’s going on?

Here’s an idea
Einhorn’s beef with Apple Inc. (NASDAQ:AAPL) is one that investors have heard before: the company’s capital allocation strategy needs to be improved. Just yesterday there was talk from mutual fund guru Bill Miler about how a significant dividend increase could make the balance sheet a catalyst and send shares higher.

In order to address this problem, Einhorn made a suggestion to the company last year that could satisfy everyone, including Apple Inc. (NASDAQ:AAPL). The notion is to create a new class of perpetual preferred shares that would be distributed to existing shareholders at no cost to the company. Perpetual preferred stocks pay dividends indefinitely and have no maturity date. If Apple were to institute a healthy 4% yield on these shares, then that would be mighty tempting for value and income investors that can bank on those dividends.

At the same time, it wouldn’t require any immediate capital outlay so Apple Inc. (NASDAQ:AAPL) could maintain its current $137.1 billion war chest for all the strategic purposes that it’s always hoarded money while also avoiding the need to bring cash home and pay repatriation taxes. In Einhorn’s opinion, such a move would do wonders to unlock the value within the balance sheet for shareholders, rewarding them directly for Apple’s tremendous success.

By Greenlight’s estimates, every $50 billion of perpetual preferred shares that Apple distributes could unlock approximately $30 billion, or $32 per share, in value. At a 4% yield, each $50 billion block only costs Apple $2 billion per year. Compare that to the current $10 billion it pays out in dividends right now. Based on these figures, Einhorn believes Apple could easily “unlock hundreds of billions of dollars of shareholder value.”

Five months ago, Apple rejected this idea outright when Greenlight brought it up. However, Apple has offered to reconsider the idea now. Where does the lawsuit come in?

Rallying the troops
Apple’s annual meeting is around the corner (Feb. 27), and as such the company has recently distributed its proxy statement for the fiscal year. The company has proposed an amendment to its articles of incorporation, which includes the elimination of Apple’s ability to issue preferred stock, which would effectively nullify Einhorn’s idea.

Apple currently does not have a preferred share class, and says the board has no intention to issue preferred stock in the future. The last time Apple issued preferred shares was when Microsoft Corporation (NASDAQ:MSFT) bailed out the company in 1997 with a $150 million investment. The software giant received 150,000 shares of convertible preferreds that it subsequently converted into a total of 18.2 million common shares between 2000 and 2001. At the peak, those shares would have been worth $12.8 billion (an 85-bagger), but unfortunately the company liquidated its position way back in 2003.

The issue is that this proposal is bundled with other changes involving majority voting for directors and establishing a par value for common shares, both of which are considered positive for corporate governance. Shareholders must vote on all three of these items with one vote, which Einhorn maintains violates the SEC’s proxy rules. He is suing to have Apple unbundle these matters so that shareholders may vote for them separately.

As it stands, Einhorn is urging fellow Apple shareholders to vote against Proposal 2 due to the provision on preferreds. I’d encourage all Apple investors out there to review the information. Einhorn’s letter can be found here (link opens PDF), and Apple’s proxy is here (link opens PDF, Proposal 2 begins on page 39).

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!